HempFusion: A Health and Wellness Leader to IPO on the TSX Senior Board


Ryan Allway

November 6th, 2020

App, Exclusive, News, Top Story


Cannabidiol, better known as CBD, has become one of the fastest growing segments of the health and wellness industry. According to BDS Analytics and ArcView, CBD sales will grow at a 49% compound annual growth rate to exceed $20 billion by 2024. 

There are very few companies in the sector have the quality, scale and expertise of HempFusion Wellness Inc. With distribution in over 4,000 retail locations across all 50 states along with a nationwide ecommerce presence, the company is one of the most recognisable CBD brands in the country—and they plan to IPO on the TSX (Senior Board) in November under the symbol CBD.U.

Let’s take a closer look at the company’s unique approach to the market, why it’s well positioned to scale up and how investors can profit from its success.

Click here to receive and investor presentation and IPO alert

Innovative Product Line Up

HempFusion has a wellness portfolio that consists of nearly 50 products, with an additional 30 under development.

The company’s primary focus has been on FDA Drug Listed Over-The-Counter (“OTC”) Topicals that permit substantiated health claims. With strict compliance standards that take significant time and money to achieve, the company’s OTC product line faces little competition with a high barrier to entry. It’s also one of the few companies that meet the strict compliance standards of large national retailers.

The company’s OTC topical products include:

  • OTC Pain Cream
  • OTC Eczema Cream
  • OTC Acne & Beauty/Aging Creams
  • OTC Wound Healing/First Aid Ointment

In addition to these products, the company offers a line of hemp extract tinctures, capsules and a line of probiotics. The latter creates a potential gateway into retailers that may not carry CBD products, enabling the company to build relationships that could ultimately result in its CBD products reaching more store shelves.

The company’s HF Labs and Biome Research divisions are simultaneously focused on reaching practitioners, including doctors and licensed chiropractors. This channel could provide higher margin opportunities and create lasting relationships with consumers that may transition to their over-the-counter products.

Well-Positioned for Growth

HempFusion has vast distribution through a variety of retailers, including Amazon.com, The Vitamin Shoppe, Whole Foods Market, Sprouts Farmers Market and more. After targeting the natural channels, the company has shifted its focus to ecommerce, Big Box (e.g. Walmart, Kroger, Walgreens, CVS, etc.) and convenience stores (e.g. 7Eleven, QuikTrip, etc.).

The company has the financial flexibility to scale with the second-largest cash position in the industry, which stands at about US$18,000,000 as of June 2020.. In addition, the company is in the middle of an ipo raise and plans to go public in November, which could provide fresh capital to support its ambitious plans to target 150,000+ retail locations over time.

Of course, it helps that HempFusion is led by an experienced management team that has raised hundreds of millions of dollars within the cannabis sector. The company has also been expanding its board of directors to include leaders in public company finance, mergers and acquisitions, consumer packaged goods and other critical areas of expertise.

Click here to receive and investor presentation and IPO alert

Going Public Soon

HempFusion Wellness Inc. plans to become the first U.S.-based CBD company to IPO directly onto the TSX (the senior board in Canada). In addition to accelerating its ability to scale, the move will provide retail (individual) investors with an opportunity to participate in the company’s upside potential through a conventional brokerage account.

The company plans to go public soon. If you’re interested in receiving an alert and further information, sign up now to download the investor presentation and receive an IPO alert when it happens!

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading